李丽,方亮
LI Li1,2

• 1:沈阳药科大学药学院
• 2:辽宁大学药学院

摘要(Abstract)：

目的介绍纳米药物载体在经皮给药系统中的应用。方法查阅国内外文献共31篇,从纳米药物载体在经皮给药系统中的应用及各自的优势和不足等方面进行综述。结果纳米药物载体具有提高药物的化学稳定性、促进药物经皮吸收、控制药物释放以及定位给药等优点,在药物的经皮吸收方面具有广阔应用前景。结论纳米药物载体为药物的经皮通透提供了新的途径和方法,但是其安全性和有效性仍需进一步研究。
Objective To summarize the latest research development of nano-drug carriers on transdermal drug delivery.Methods According to the recent relevant literature,the advantage of nano-drug carriers on transdermal drug delivery and their application in the pharmaceutical field were summarized.Their development prospect and unsolved problems were pointed out.Results The nano-drug carriers are characterized by improvement of chemical stability of actives,enhancement percutaneous absorption of drugs,controlling release and targeting.Nano-drug carriers have broad prospects in the transdermal drug delivery.Conclusions The nano-drug carriers provide a new means for drugs permeation through skin.However,the research on their security and effectiveness must be investigated further.

关键词(KeyWords)： 纳米药物;载体;经皮给药系统
nano-drug;carrier;transdermal drug delivery system

Abstract:

Keywords:

基金项目(Foundation): 国家科技部重大新药创制项目(2008ZX09401-004)

作者(Author): 李丽,方亮
LI Li1,2

DOI: 10.14066/j.cnki.cn21-1349/r.2010.12.011

参考文献(References)：

• [1]蔡霞.纳米乳在透皮给药系统中的应用概况[J].广东药学院学报,2009,25(4):429-432.
• [2]张莉,张鹏威,石峰,等.辣椒碱纳米乳的制备及大鼠透皮实验研究[J].中国药房,2009,20(34):2657-2659.
• [3]朱晓亮,李国锋,曾抗,等.利多卡因纳米乳制备及体外经皮吸收的实验研究[J].南方医科大学学报,2010,30(3):451-454.
• [4]KREILGAARD M.Dermal pharmacokinetics of microe-mulsion formulations determined byin vivomicrodialys-is[J].Pharm Res,2001,18(3):367-373.
• [5]SANTOS P,WATKINSON A C,HADGRAFT J,et al.Application of microemulsions in dermal and transder-mal drug delivery[J].Skin Pharmacol Physiol,2008,21(5):246-259.
• [6]朱晓亮.纳米乳透过作用机制及利多卡因纳米乳透皮局麻制剂的研究[D].广州:第一军医大学,2007,2-3.
• [7]SHAKEEL F,BABOOTA S,AHUJA A,et al.Celecoxibnanoemulsion:skin permeation mechanism and bio-availability assessment[J].J Drug Target,2008,16(10):733-740.
• [8]KUMAR D,AQIL M,SULTANA Y,et al.Investigationof a nanoemulsion as vehicle for transdermal delivery ofamlodipine[J].Pharmazie,2009,64(2):80-85.
• [9]朱晓亮,李国锋,陈志良,等.纳米乳的皮肤刺激性研究[J].中国医药工业杂志,2007,38(2):105-108.
• [10]KITAGAWA S,KASAMAKI M.Enhanced delivery ofretinoic acid to skin by cationic liposomes[J].ChemPharm Bull,2006,54(2):242-244.
• [11]PUGLIA C,TROMBETTA D,VENUTI V,et al.Evalu-ation of in-vivo topical anti-inflammatory activity of in-dometacin from liposomal vesicles[J].J Pharm Phar-macol,2004,56(10):1225-1232.
• [12]FRESTA M,PUGLISI G.Corticosteroid dermal deliverywith skin-lipid liposomes[J].J Control Release,1997,44(2-3):141-151.
• [13]KIRJAVAINEN M,URTTI A,JAASKELAINEN I,etal.Interaction of liposomes with human skinin vitrothe influence of lipid composition and structure[J].Biochim Biophys Acta,1996,1304(4):179-189.
• [14]HONEYWELL-NGUYEN P L,ARENJA S,BOUW-STRA J A.Skin penetration and mechanisms of actionin the delivery of the D2-agonist rotigotine from surfac-tant-based elastic vesicle formulations[J].PharmRes,2003,20(10):1619-1625.
• [15]MUSTAFA M A,OSSAMA Y A,VIVIANE F N,et al.Lipid vesicles for skin delivery of drugs:reviewingthree decades of research[J].Int J Pharm,2007,332(1-2):1-16.
• [16]SIMONA M,MARIA M,CHIARA S,et al.Penetrationenhancer-containing vesicles(PEVs)as carriers for cu-taneous delivery of minoxidil[J].Int J Pharm,2009,380(1-2):72-79.
• [17]刘波,张阳德,廖明媚,等.吲哚美辛柔性纳米脂质体与普通纳米脂质体体外透皮速率的比较[J].中国组织工程研究与临床康复,2009,13(12):2261-2264.
• [18]魏颖慧,陈苹苹,李范珠.囊泡及微粒经皮给药系统的研究进展[J].中国医药工业杂志,2010,41(3):224-229.
• [19]HONEYWELL-NGUYEN P L,BOUWSTRA J A.Thein vitrotransport of pergolide from surfactant-based e-lastic vesicles through human skin:a suggested mecha-nism of action[J].J Control Release,2003,86(1):145-156.
• [20]TOUITOU E,DAYAN N,BERGELSON L,et al.Etho-somes-novel vesicular carriers for enhanced delivery:haracterization and skin penetration properties[J].JControlled Release,2000,65(3):403-418.
• [21]RAO Y F,ZHENG F Y,ZHANG X G,et al.In vitropercutaneous permeation and skin accumulation of fin-asteride using vesicular ethosomal carriers[J].AAPSPharmSciTech,2008,9(3):860-865.
• [22]ZHAO W Z,XIAO L W,YANG D Z,et al.Preparationof matrine ethosome,its percutaneous permeation invitro and anti-inflammatory activity in vivo in rats[J].J Lipsome Res,2009,19(2):155-162.
• [23]GAMER A O,LEIBOLD E,Ravenzwaay B V.The invitro absorption of microfine zinc oxide and titaniumdioxide through porcine skin[J].Toxicol In Vitro,2006,20(3):301-307.
• [24]SHIM J,KANG H S,PARK W S,et al.Transdermaldelivery of mixnoxidil with block copolymer nanoparti-cles[J].J Control Release,2004,97(3):477-484.
• [25]GREGOR C,ULRICH V.Nanotechnology and thetransdermal route a state of the art review and criticalappraisal[J].J Control Release,2010,141(3):277-299.
• [26]SCHAFER K M,MEHNERTW,KORTING H C.Lipidnanoparticles for improved topical application of drugsfor skin diseases[J].Adv Drug Deliv Rev,2007,59(6):427-443.
• [27]SANNA V,GAVINI E,COSSU M,et al.Solid lipidnanoparticles(SLN)as carriers for the topical deliveryof econazole nitrate:in-vitrocharacterization,ex-vivoand in-vivo studies[J].J Pharm Pharmacol,2007,59(8):1057-1064.
• [28]JOSHI M,PATRAVAL E V.Formulation and evalua-tion of nanostructured lipid carrier(NLC)based gel ofvaldecoxib[J].Drug Dev Ind Pharm,2006,32(8):911-918.
• [29]JOSHI M,PATRAVAL E V.Nanostructured lipid carri-er(NLC)based gel of celecoxib[J].Int J Pharm,2008,346(1-2):124-132.
• [30]韩飞,刘洪卓,李三鸣.固体脂质纳米粒和纳米结构脂质载体在经皮给药系统中的研究进展[J].沈阳药科大学学报,2008,25(10):839-844.
• [31]JANA P,AIMAN H,RAINER H M.Lipid nanoparti-cles(SLN,NLC)in cosmetic and pharmaceutical der-mal products[J].Int J Pharm,2009,366(1-2):170-184.